Fig. 8From: Receptor-based pharmacophore modeling, molecular docking, synthesis and biological evaluation of novel VEGFR-2, FGFR-1, and BRAF multi-kinase inhibitors2D diagram (A) and 3D representation (B) of compound 8u showing its interaction with the FGFR-1 active siteBack to article page